chemotherapy: be used for breast cancer

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be used for breast cancer 1.00
be for cancer 0.90
affect breast 0.90
be just used for cancer 0.88
be more common in breast 0.88
be for just cancer 0.88
be more common in left breast 0.86
has state cancer 0.86
treat cancer 0.83
be effective in cancer treatment 0.83

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.48
Rule weight: 0.66
Evidence weight: 0.88
Similarity weight: 0.83
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.79
¬ Typical(chemotherapy, be used for breast cancer)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.84
Similarity weight: 0.83
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.85
¬ Plausible(agent, be effective in cancer treatment)

Remarkability exclusitivity betweem a parent and a child

0.32
Rule weight: 0.58
Evidence weight: 0.67
Similarity weight: 0.83
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment)

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.55
Similarity weight: 0.83
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.58
¬ Remarkable(gene therapy, treat cancer)
0.04
Rule weight: 0.13
Evidence weight: 0.36
Similarity weight: 0.86
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.83
¬ Remarkable(breast cancer, be more common in left breast)
0.04
Rule weight: 0.13
Evidence weight: 0.33
Similarity weight: 0.86
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.86
¬ Remarkable(breast cancer, has state cancer)
0.03
Rule weight: 0.13
Evidence weight: 0.26
Similarity weight: 0.88
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.96
¬ Remarkable(breast cancer, be more common in breast)
0.03
Rule weight: 0.13
Evidence weight: 0.23
Similarity weight: 0.90
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 1.00
¬ Remarkable(breast cancer, affect breast)

Remarkability from parent implausibility

0.34
Rule weight: 0.42
Evidence weight: 0.97
Similarity weight: 0.83
Evidence: 0.85
Plausible(agent, be effective in cancer treatment) ⋁
Evidence: 0.77
Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.81
¬ Plausible(chemotherapy, be used for breast cancer)

Remarkability from sibling implausibility

0.54
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.90
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 1.00
Remarkable(breast cancer, affect breast) ⋁
Evidence: 0.15
¬ Plausible(breast cancer, affect breast)
0.53
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.88
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.96
Remarkable(breast cancer, be more common in breast) ⋁
Evidence: 0.31
¬ Plausible(breast cancer, be more common in breast)
0.52
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.86
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.86
Remarkable(breast cancer, has state cancer) ⋁
Evidence: 0.32
¬ Plausible(breast cancer, has state cancer)
0.51
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.86
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.83
Remarkable(breast cancer, be more common in left breast) ⋁
Evidence: 0.51
¬ Plausible(breast cancer, be more common in left breast)
0.47
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.83
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.58
Remarkable(gene therapy, treat cancer) ⋁
Evidence: 0.84
¬ Plausible(gene therapy, treat cancer)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.92
¬ Salient(chemotherapy, be used for breast cancer)

Similarity expansion

0.72
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.92
Salient(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.81
¬ Salient(chemotherapy, be for cancer)
0.70
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.88
Evidence: 0.92
Salient(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.89
¬ Salient(chemotherapy, be just used for cancer)
0.70
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.88
Evidence: 0.92
Salient(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.94
¬ Salient(chemotherapy, be for just cancer)
0.68
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.90
Evidence: 0.79
Typical(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.52
¬ Typical(chemotherapy, be for cancer)
0.68
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.90
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.61
¬ Plausible(chemotherapy, be for cancer)
0.65
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.88
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.73
¬ Plausible(chemotherapy, be just used for cancer)
0.65
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.88
Evidence: 0.79
Typical(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.68
¬ Typical(chemotherapy, be just used for cancer)
0.64
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.88
Evidence: 0.77
Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
0.63
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.88
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.87
¬ Plausible(chemotherapy, be for just cancer)
0.62
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.90
Evidence: 0.77
Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
0.62
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.88
Evidence: 0.77
Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.81
¬ Remarkable(chemotherapy, be just used for cancer)
0.61
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.88
Evidence: 0.79
Typical(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.90
¬ Typical(chemotherapy, be for just cancer)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.92
Salient(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.79
¬ Typical(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer)

Typical implies Plausible

0.41
Rule weight: 0.48
Evidence weight: 0.85
Similarity weight: 1.00
Evidence: 0.81
Plausible(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.79
¬ Typical(chemotherapy, be used for breast cancer)

Typicality and Rermarkability incompatibility between a parent and a child

0.11
Rule weight: 0.51
Evidence weight: 0.27
Similarity weight: 0.83
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)

Typicality and Rermarkability incompatibility between siblings

0.12
Rule weight: 0.14
Evidence weight: 1.00
Similarity weight: 0.90
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.00
¬ Typical(breast cancer, affect breast)
0.11
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 0.88
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.09
¬ Typical(breast cancer, be more common in breast)
0.10
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 0.86
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.17
¬ Typical(breast cancer, has state cancer)
0.08
Rule weight: 0.14
Evidence weight: 0.67
Similarity weight: 0.86
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.43
¬ Typical(breast cancer, be more common in left breast)
0.03
Rule weight: 0.14
Evidence weight: 0.31
Similarity weight: 0.83
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.89
¬ Typical(gene therapy, treat cancer)

Typicality inheritance from parent to child

0.32
Rule weight: 0.48
Evidence weight: 0.80
Similarity weight: 0.83
Evidence: 0.79
Typical(chemotherapy, be used for breast cancer) ⋁
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)